In addition, previous studies have documented the upregulation of miR-206 in the hippocampus, CSF, and plasma of animal models for AD, such as Tg2576 and APP/PS1 transgenic mice, as well as in the brains of patients with AD. Here, APP is linked to Alzheimer disease.